Health Insurance Coverage Limitations of Anti-Integrin Therapy in Ulcerative Colitis and Their Impact on Anti-Tumor Necrosis Factor (Anti-TNF) Therapy Utilization

被引：0
作者：
John, Eric [1 ]
机构：
[1] Spherix Global Insights, Exton, PA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2021年 / 116卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S801
引用
收藏
页码：S371 / S371
页数：1
相关论文
共 50 条
  • [31] Successful Switch of Patients with Rheumatoid Arthritis Developing Anti-tumor Necrosis Factor (anti-TNF)-induced Lupus to Another Anti-TNF Agent
    Ye, Carrie
    Sholter, Dalton
    Martin, Liam
    Keeling, Stephanie
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (06) : 1216 - 1217
  • [32] Psoriasiform Reactions to Anti-Tumor Necrosis Factor α Therapy
    Nguyen, Khang
    Vleugels, Ruth Ann
    Velez, Nicole F.
    Merola, Joseph F.
    Qureshi, Abrar A.
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2013, 19 (07) : 377 - 381
  • [33] Economic Burden of Switching to an Anti-Tumor Necrosis Factor (anti-TNF) Versus a Non-Tumor Necrosis Factor (non-TNF) Biologic Therapy Among Patients with Rheumatoid Arthritis
    Zhou, Zheng-Yi
    Griffith, Jenny
    Ganguli, Arijit
    Du, Ella Xiaoyan
    Betts, Keith
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [34] Anti-tumor necrosis factor therapy -: Experiences with Etanercept
    Nüsslein, HG
    AKTUELLE RHEUMATOLOGIE, 2000, 25 (03) : 79 - 82
  • [35] Predicting the future of anti-tumor necrosis factor therapy
    Verweij, Cornelis L.
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (03)
  • [36] Predicting the future of anti-tumor necrosis factor therapy
    Cornelis L Verweij
    Arthritis Research & Therapy, 11
  • [37] The impact of anti-TNF therapy on the nonspecialist
    Mandell, Brian F.
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2014, 81 (02) : 71 - 72
  • [38] CONFOCAL LASER ENDOMICROSCOPY REVEALS DIFFERENTIAL RESPONSE IN PATIENTS WITH ACTIVE ULCERATIVE COLITIS UNDERGOING ANTI-INTEGRIN COMPARED TO ANTI-TNF-ALPHA THERAPY
    Ellrichmann, Mark
    Bethge, Johannes
    Aust, Golo
    Lautenschlaeger, Ingmar
    Schulte, Berenice
    Arlt, Alexander
    Aden, Konrad
    Schreiber, Stefan
    GASTROINTESTINAL ENDOSCOPY, 2019, 89 (06) : AB68 - AB69
  • [39] Genetic Markers Predict Primary Nonresponse and Durable Response to Anti-Tumor Necrosis Factor Therapy in Ulcerative Colitis
    Burke, Kristin E.
    Khalili, Hamed
    Garber, John J.
    Haritunians, Talin
    McGovern, Dermot P. B.
    Xavier, Ramnik J.
    Ananthakrishnan, Ashwin N.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (08) : 1840 - 1848
  • [40] ANTI-TUMOR THERAPY BY INDUCTION OF ENDOGENOUS TUMOR NECROSIS FACTOR
    KATO, M
    KAKEHI, R
    SOMA, GI
    GATANAGA, T
    MIZUNO, D
    LANCET, 1985, 2 (8449) : 270 - 270
12345